Clinical protocol. An open-label, phase I, dose-escalation study of tumor necrosis factor-alpha (TNFerade Biologic) gene transfer with radiation therapy for locally advanced, recurrent, or metastatic solid tumors.

Clinical protocol. An open-label, phase I, dose-escalation study of tumor necrosis factor-alpha (TNFerade Biologic) gene transfer with radiation therapy for locally advanced, recurrent, or metastatic solid tumors. Hum Gene Ther. 2001 Jun 10; 12(9):1109-31.

View in: PubMed

subject areas

Adverse Drug Reaction Reporting Systems
Clinical Protocols
Clinical Trials, Phase I as Topic
Combined Modality Therapy
Drug Administration Schedule
Female
Gene Transfer Techniques
Humans
Male
Neoplasm Metastasis
Neoplasms
Patient Selection
Tumor Necrosis Factor-alpha

authors with profiles

Ralph R. Weichselbaum